261 related articles for article (PubMed ID: 17073518)
1. Atypical cytochrome p450 kinetics: implications for drug discovery.
Tracy TS
Drugs R D; 2006; 7(6):349-63. PubMed ID: 17073518
[TBL] [Abstract][Full Text] [Related]
2. In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model.
Houston JB; Kenworthy KE
Drug Metab Dispos; 2000 Mar; 28(3):246-54. PubMed ID: 10681367
[TBL] [Abstract][Full Text] [Related]
3. Modeling kinetic data from in vitro drug metabolism enzyme experiments.
Tracy TS; Hummel MA
Drug Metab Rev; 2004 May; 36(2):231-42. PubMed ID: 15237853
[TBL] [Abstract][Full Text] [Related]
4. Atypical enzyme kinetics: their effect on in vitro-in vivo pharmacokinetic predictions and drug interactions.
Tracy TS
Curr Drug Metab; 2003 Oct; 4(5):341-6. PubMed ID: 14529366
[TBL] [Abstract][Full Text] [Related]
5. Atypical Michaelis-Menten kinetics in cytochrome P450 enzymes: A focus on substrate inhibition.
Leow JWH; Chan ECY
Biochem Pharmacol; 2019 Nov; 169():113615. PubMed ID: 31445022
[TBL] [Abstract][Full Text] [Related]
6. Modelling atypical CYP3A4 kinetics: principles and pragmatism.
Houston JB; Galetin A
Arch Biochem Biophys; 2005 Jan; 433(2):351-60. PubMed ID: 15581591
[TBL] [Abstract][Full Text] [Related]
7. Atypical kinetics of cytochrome P450 enzymes in pharmacology and toxicology.
Leow JWH; Tang LWT; Chan ECY
Adv Pharmacol; 2022; 95():131-176. PubMed ID: 35953154
[TBL] [Abstract][Full Text] [Related]
8. Heterotropic cooperativity in oxidation mediated by cytochrome p450.
Niwa T; Murayama N; Yamazaki H
Curr Drug Metab; 2008 Jun; 9(5):453-62. PubMed ID: 18537580
[TBL] [Abstract][Full Text] [Related]
9. Fundamentals of Enzyme Kinetics: Michaelis-Menten and Non-Michaelis-Type (Atypical) Enzyme Kinetics.
Seibert E; Tracy TS
Methods Mol Biol; 2021; 2342():3-27. PubMed ID: 34272689
[TBL] [Abstract][Full Text] [Related]
10. Enzyme Kinetics of Oxidative Metabolism-Cytochromes P450.
Korzekwa K
Methods Mol Biol; 2021; 2342():237-256. PubMed ID: 34272697
[TBL] [Abstract][Full Text] [Related]
11. Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions.
Atkins WM
Annu Rev Pharmacol Toxicol; 2005; 45():291-310. PubMed ID: 15832445
[TBL] [Abstract][Full Text] [Related]
12. Enzyme kinetics of oxidative metabolism: cytochromes P450.
Korzekwa K
Methods Mol Biol; 2014; 1113():149-66. PubMed ID: 24523112
[TBL] [Abstract][Full Text] [Related]
13. Studying cytochrome P450 kinetics in drug metabolism.
Kramer MA; Tracy TS
Expert Opin Drug Metab Toxicol; 2008 May; 4(5):591-603. PubMed ID: 18484917
[TBL] [Abstract][Full Text] [Related]
14. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat.
Witherow LE; Houston JB
J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760
[TBL] [Abstract][Full Text] [Related]
15. [Research progress of the atypical kinetic profiles of cytochrome P450 enzymes].
Zeng CW; He F; Xia CH; Xiong YQ
Yao Xue Xue Bao; 2012 Jun; 47(6):725-9. PubMed ID: 22919718
[TBL] [Abstract][Full Text] [Related]
16. Enzyme kinetics of cytochrome P450-mediated reactions.
Shou M; Lin Y; Lu P; Tang C; Mei Q; Cui D; Tang W; Ngui JS; Lin CC; Singh R; Wong BK; Yergey JA; Lin JH; Pearson PG; Baillie TA; Rodrigues AD; Rushmore TH
Curr Drug Metab; 2001 Mar; 2(1):17-36. PubMed ID: 11465149
[TBL] [Abstract][Full Text] [Related]
17. Substrate inhibition kinetics for cytochrome P450-catalyzed reactions.
Lin Y; Lu P; Tang C; Mei Q; Sandig G; Rodrigues AD; Rushmore TH; Shou M
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):368-74. PubMed ID: 11259318
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cytochrome P450 enzymes by saturated and unsaturated fatty acids in human liver microsomes, characterization of enzyme kinetics in the presence of bovine serum albumin (0.1 and 1.0% w/v) and in vitro - in vivo extrapolation of hepatic clearance.
Palacharla RC; Uthukam V; Manoharan A; Ponnamaneni RK; Padala NP; Boggavarapu RK; Bhyrapuneni G; Ajjala DR; Nirogi R
Eur J Pharm Sci; 2017 Apr; 101():80-89. PubMed ID: 28179134
[TBL] [Abstract][Full Text] [Related]
19. Comparison of fresh and cryopreserved rat hepatocyte suspensions for the prediction of in vitro intrinsic clearance.
Griffin SJ; Houston JB
Drug Metab Dispos; 2004 May; 32(5):552-8. PubMed ID: 15100178
[TBL] [Abstract][Full Text] [Related]
20. Application of modified Michaelis - Menten equations for determination of enzyme inducing and inhibiting drugs.
Saganuwan SA
BMC Pharmacol Toxicol; 2021 Oct; 22(1):57. PubMed ID: 34635182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
